Product information and disease descriptionPlace of product in therapyDisease description
Epidemiology
9 evidence topics · 6 sources
Atebrioz (zilurgisertib)
Fibrodysplasia ossificans progressiva
- Manufacturer
- Mirum Pharmaceuticals
- Regulatory submission
- NDA submitted by May 2026
- Last updated